{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:07:42Z","timestamp":1784041662842,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["202303021211201"],"award-info":[{"award-number":["202303021211201"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019933","name":"Shanxi Collaborative Innovation Center of High Value-added Utilization of Coal-related Wastes","doi-asserted-by":"publisher","award":["202204010501004"],"award-info":[{"award-number":["202204010501004"]}],"id":[{"id":"10.13039\/501100019933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00464-026-12710-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:35:23Z","timestamp":1776872123000},"page":"5847-5857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Milan versus up-to-seven criteria for liver resection in hepatocellular carcinoma: a multi-center study on risk factors and long-term outcomes"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-0664","authenticated-orcid":false,"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-ning","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-guang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dui-ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-bo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"12710_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"12710_CR2","doi-asserted-by":"crossref","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, Anaya DA, Anders R, Are C et al (2021) Hepatobiliary cancers, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19:541\u2013565","DOI":"10.6004\/jnccn.2021.0022"},{"key":"12710_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"PR Galle","year":"2018","unstructured":"Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L et al (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182\u2013236","journal-title":"J Hepatol"},{"key":"12710_CR4","doi-asserted-by":"publisher","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Author correction: hepatocellular carcinoma. Nature Reviews. Disease Primers. 2024;10(1):10.https:\/\/doi.org\/10.1038\/S41572-020-00240-3.","DOI":"10.1038\/S41572-020-00240-3"},{"key":"12710_CR5","doi-asserted-by":"crossref","unstructured":"Tong Y, Cai R, Li JX, Chang DH, Wang LZ, Cai WW, Xiao YD (2022) Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis. Aliment Pharmacol Ther 56(11-12):1602\u20131614","DOI":"10.1111\/apt.17263"},{"key":"12710_CR6","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhang H, Meng Q, Zhang DZ, Wu SS, Hong ZX, He GB, Yang H, Xiang BD, Li X, Jiang TA (2024) A multicenter case\u2013controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3\u20135 cm hepatocellular carcinoma in patients aged 60 and older. Int J Surg 110(3):1356\u20131366","DOI":"10.1097\/JS9.0000000000000839"},{"key":"12710_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061798","volume":"15","author":"T Hatanaka","year":"2023","unstructured":"Hatanaka T, Yata Y, Naganuma A, Kakizaki S (2023) Treatment strategy for intermediate-stage hepatocellular carcinoma: transarterial chemoembolization, systemic therapy, and conversion therapy. Cancers Basel 15:1798","journal-title":"Cancers Basel"},{"key":"12710_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301\u20131314","journal-title":"Lancet"},{"key":"12710_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijsu.2018.06.026","volume":"56","author":"Z Deng","year":"2018","unstructured":"Deng Z, Jiang W, Tang X, Liu S, Qin L, Qian H (2018) Laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 157 patients: a case controlled study with propensity score matching at two Chinese centres. Int J Surg 56:203\u2013207","journal-title":"Int J Surg"},{"key":"12710_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.21037\/hbsn.2016.12.09","volume":"5","author":"Z Zhu","year":"2016","unstructured":"Zhu Z (2016) Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma. Hepatobiliary Surg Nutr 5:498\u2013502","journal-title":"Hepatobiliary Surg Nutr"},{"key":"12710_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejso.2021.08.035","volume":"48","author":"H Feng","year":"2022","unstructured":"Feng H, Yang C, Xu F, Zhao Y, Jin T, Wei Z et al (2022) Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis. Eur J Surg Oncol 48:418\u2013424","journal-title":"Eur J Surg Oncol"},{"key":"12710_CR12","doi-asserted-by":"crossref","unstructured":"Kitano Y et al (2022) The efficacy of anatomic resection for hepatocellular carcinoma within Milan criteria: A retrospective single-institution case-matched study. Eur J Surg Oncol 48(9):2008\u20132013. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35599139\/. Cited 2025 Jun 22","DOI":"10.1016\/j.ejso.2022.05.004"},{"key":"12710_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35\u201343","journal-title":"Lancet Oncol"},{"key":"12710_CR14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.surg.2022.05.023","volume":"172","author":"Z-H Feng","year":"2022","unstructured":"Feng Z-H, Wang M-D, Chen Z, Sun L-Y, Xu X, Kong Q-Y et al (2022) Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0\/A hepatocellular carcinoma: a large-scale multicenter study. Surgery 172:1147\u20131155","journal-title":"Surgery"},{"key":"12710_CR15","doi-asserted-by":"crossref","unstructured":"Lim K-C, Chow PK-H, Allen JC, Siddiqui FJ, Chan ES-Y, Tan S-B (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99:1622\u20139","DOI":"10.1002\/bjs.8915"},{"key":"12710_CR16","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1007\/s00330-020-07460-x","volume":"31","author":"Y Yang","year":"2021","unstructured":"Yang Y, Chen Y, Ye F, Cao X, Xin Y, Wang Y et al (2021) Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival. Eur Radiol 31:3053\u20133064","journal-title":"Eur Radiol"},{"key":"12710_CR17","doi-asserted-by":"crossref","unstructured":"Yang Y, Chen Y, Zhang X, Xin Y, Wang Y, Li X, Fan Q, Zhou X, Ye F (2021) Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study. Eur J Radiol 138:109623","DOI":"10.1016\/j.ejrad.2021.109623"},{"key":"12710_CR18","doi-asserted-by":"crossref","unstructured":"Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY (2019) Radiomics on gadoxetic acid\u2013enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res 25(13):3847\u20133855","DOI":"10.1158\/1078-0432.CCR-18-2861"},{"key":"12710_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","volume":"154","author":"X-F Xu","year":"2019","unstructured":"Xu X-F, Xing H, Han J, Li Z-L, Lau W-Y, Zhou Y-H et al (2019) Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg 154:209\u2013217","journal-title":"JAMA Surg"},{"key":"12710_CR20","doi-asserted-by":"crossref","unstructured":"Yan WT, Li C, Yao LQ, Qiu HB, Wang MD, Xu XF, Zhou YH, Wang H, Chen TH, Gu WM, Zhong JH (2021) Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study. Hepatobiliary Surg Nutr 12(2):155","DOI":"10.21037\/hbsn-21-288"},{"key":"12710_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver (2025) EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol 82:315\u2013374","journal-title":"J Hepatol"},{"key":"12710_CR22","doi-asserted-by":"crossref","unstructured":"Zhuang BW, Li W, Wang W, Li B, Lu MD, Kuang M, Xie XH, Xie XY (2021) Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study. Eur Radiol 31(7):5379\u20135389","DOI":"10.1007\/s00330-020-07551-9"},{"key":"12710_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21037\/hbsn-21-350","volume":"11","author":"JH Koh","year":"2022","unstructured":"Koh JH, Tan DJH, Ong Y, Lim WH, Ng CH, Tay PWL et al (2022) Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients. Hepatobiliary Surg Nutr 11:78\u201393","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"12710_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.surg.2024.02.006","volume":"176","author":"CY Hsiao","year":"2024","unstructured":"Hsiao CY, Ho CM, Ho MC, Cheng HY, Wu YM, Lee PH et al (2024) Risk factors, patterns, and outcome predictors of late recurrence in patients with hepatocellular carcinoma after curative resection: A large cohort study with long-term follow-up results. Surgery 176(1):2\u201310","journal-title":"Surgery"},{"key":"12710_CR25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.ejso.2019.04.008","volume":"45","author":"M Li","year":"2019","unstructured":"Li M, Wang Z, Cao J, Han B, Zou H, Zang Y et al (2019) Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections. Eur J Surg Oncol 45:1684\u20131690","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"12710_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s11605-023-05618-8","volume":"27","author":"F Xia","year":"2023","unstructured":"Xia F, Zhang Q, Zheng J, Huang Z, Ndhlovu E, Gao H (2023) Risk factors of positive resection margin in hepatectomy for resectable ruptured hepatocellular carcinoma: Risk prediction and prognosis. J Gastrointest Surg 27(7):1400\u20131411","journal-title":"J Gastrointest Surg"},{"key":"12710_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.109486","volume":"51","author":"Y Shen","year":"2025","unstructured":"Shen Y, Hu Y-L, Xu J-H, Zhu S, Cai L, Wu Y-F et al (2025) Incidence, risk factors, outcomes, and prediction model of surgical site infection after hepatectomy for hepatocellular carcinoma: a multicenter cohort study. Eur J Surg Oncol 51:109486","journal-title":"Eur J Surg Oncol"},{"key":"12710_CR28","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/SLA.0000000000005380","volume":"277","author":"P Zhu","year":"2023","unstructured":"Zhu P, Liao W, Zhang W-G, Chen L, Shu C, Zhang Z-W et al (2023) A prospective study using propensity score matching to compare long-term survival outcomes after robotic-assisted, laparoscopic, or open liver resection for patients with BCLC stage 0-A hepatocellular carcinoma. Ann Surg 277:e103\u2013e111","journal-title":"Ann Surg"},{"key":"12710_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/bjs\/znaa041","volume":"108","author":"RI Troisi","year":"2021","unstructured":"Troisi RI, Berardi G, Morise Z, Cipriani F, Ariizumi S, Sposito C et al (2021) Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study. Br J Surg 108:196\u2013204","journal-title":"Br J Surg"},{"issue":"5","key":"12710_CR30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s12072-023-10492-2","volume":"17","author":"SY Yang","year":"2023","unstructured":"Yang SY, Feng JK, Yan ML, Guo L, Duan YF, Ye JZ et al (2023) Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: Multicenter propensity score-matched study. Hepatol Int 17(5):1251\u20131264","journal-title":"Hepatol Int"},{"key":"12710_CR31","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s00464-019-06781-3","volume":"33","author":"M Xiangfei","year":"2019","unstructured":"Xiangfei M, Yinzhe X, Yingwei P, Shichun L, Weidong D (2019) Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis. Surg Endosc 33:2396\u20132418","journal-title":"Surg Endosc"},{"key":"12710_CR32","doi-asserted-by":"crossref","unstructured":"Pu JL, Xu X, Chen LL, Li C, Jia HD, Fan ZQ, Li JD, Guan MC, Liang YJ, Zhou YH, Wang XM (2023) Postoperative infectious complications following laparoscopic versus open hepatectomy for hepatocellular carcinoma: a multicenter propensity score analysis of 3876 patients. International J Surg 109(8):2267\u20132275","DOI":"10.1097\/JS9.0000000000000446"},{"issue":"1","key":"12710_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1245\/s10434-022-12749-w","volume":"30","author":"H Gon","year":"2023","unstructured":"Gon H, Kido M, Komatsu S, Fukushima K, Urade T, Nanno Y et al (2023) Safe laparoscopic resection of hepatocellular carcinoma in the Spiegel lobe of the liver using a medial-to-lateral approach. Ann Surg Oncol 30(1):383","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-12710-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12710-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:43:29Z","timestamp":1784040209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-12710-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["12710"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-12710-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Yi Chen, Wen-ji Xu, Zhe-ning Yan, Feng Liu, Chen-guang Shi, Dui-ping Feng, Yan-bo Ma and Rui-ping Zhang have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Institutional Review Board approval was obtained(KYYL-2023\u2013017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}